Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during May 2025'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec Limited has filed a routine regulatory disclosure under SEBI Regulation 74(5) reporting the dematerialization status of its shares as of May 31, 2025. The total dematerialized shares stood at 6,10,96,525 (NSDL: 5,23,83,805; CDSL: 87,12,720), up marginally by just 1,000 shares from 6,10,95,525 at the end of April 2025. During May 2025, only one shareholder (Pradeep Kumar Roy) converted 1,000 physical shares into demat form. The certificate was issued by the company's Registrar and Transfer Agent, Skyline Financial Services Pvt. Ltd.
This is a routine compliance filing with no material impact on shareholders or stock price. The tiny change of 1,000 shares indicates most shareholders already hold shares in demat form, reflecting a healthy level of digitization.